5FO7 | Lipid Binding | date | Nov 18, 2015 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Complement C3b At 2.8 Angstrom Re | ||||||||||||||
authors | F.Forneris, J.Wu, X.Xue, P.Gros | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Complement C3 Beta Chain Chain: A Fragment: Residues 23-667 Synonym: C3 And Pzp-Like Alpha-2-Macroglobulin Domain-Conta Protein 1; |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Purified From Human Plasma | ||||||||||||||
Molecule: Complement C3b Alpha' Chain Chain: B Fragment: Residues 749-1663 Synonym: C3 And Pzp-Like Alpha-2-Macroglobulin Domain-Conta Protein 1 |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Other_details: Purified From Human Plasma | ||||||||||||||
symmetry | Space Group: P 1 21 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.80 Å | ||||||||||||
ligand | NAG | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode., Forneris F, Wu J, Xue X, Ricklin D, Lin Z, Sfyroera G, Tzekou A, Volokhina E, Granneman JC, Hauhart R, Bertram P, Liszewski MK, Atkinson JP, Lambris JD, Gros P, EMBO J. 2016 Mar 24. pii: e201593673. PMID:27013439 |
Data retrieval |
View 5FO7 in 3D |
Visual 3D analysis of 5FO7 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5FO7 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |